Log In
Print
BCIQ
Print
Print this Print this
 

huN901-DM1, Lorvotuzumab mertansine (IMGN901)

Also known as: BB10901

  Manage Alerts
Collapse Summary General Information
Company ImmunoGen Inc.
DescriptionCD56 targeting antibody linked to ImmunoGen's DM1 cytotoxic agent
Molecular Target CD56
Mechanism of ActionAntibody-drug conjugate
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today